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ABSTRACT  
Background: Complex Regional Pain Syndrome (CRPS) symptoms can significantly differ between 
patients, fluctuate over time, disappear or persist. This leads to problems in defining recovery and in 
evaluating the efficacy of therapeutic interventions. 
 
Objectives: To define recovery from the patients’ perspective and better understand their priorities for 
treatment approaches. 
 
Methods: Establishing an international consortium, we used a 2-Round Delphi-based study in eight 
countries across Europe and North America. Participants ≥18 years who met, or had met, Budapest 
clinical criteria were included. Round 1 participants completed the statement: “I would/do consider 
myself recovered from CRPS if/because…” alongside demographic and health questionnaires. Data 
were thematically organised and represented as 62 statements, from which participants identified and 
ranked their recovery priorities in Round 2. 
 
Results: Round 1 (N=347, 80% female, 91% non-recovered) dominant ICF themes were: activities of 
daily living; bodily functions; external factors; participation and personal factors. The top 5 priority 
statements in Round 2 (N=252) were: no longer having 1) CRPS-related pain, 2) generalised pain 
and discomfort, 3) restricted range of movement, 4) need for medication, 5) stiffness in the affected 
limb. With very few exceptions, priorities were consistent, irrespective of patient 
demographics/geography. Symptoms affecting daily activities were among those most frequently 
reported.  
 
Conclusions: Our data showed a small number of themes are of highest importance to CRPS 
patients’ definition of recovery. Patients want their pain, movement restriction and reliance on 
medication to be addressed, above all other factors. These factors should therefore be foremost 
concerns for future treatment and rehabilitation programmes. 
 
Statement of significance: 
• Those with longstanding CRPS may no longer meet diagnostic criteria but still be 
symptomatic.  
• Defining recovery is therefore problematic in CRPS.   
• Our study has identified patients’ definition of recovery from CRPS, in order of priority, as 
relief from: their CRPS-related pain, generalised pain, movement restriction, reliance on 
medication, and stiffness. 
 
  
1. INTRODUCTION  
Complex Regional Pain Syndrome (CRPS) is a pain condition diagnosed using validated clinical 
diagnostic criteria known as the Budapest criteria (Harden et al., 2010). Signs and symptoms are 
usually limited to a single limb, which may include oedema, altered hair and nail growth, sensory, 
motor and autonomic disturbances (Harden et al., 2010). In addition, disrupted body perception and 
dis-ownership of the affected limb are commonly described (Frettlöh et al., 2006; Galer et al., 1995; 
Galer and Jensen 1999; Lewis et al., 2007; Moseley 2005). Symptoms usually develop following 
trauma to a limb but very rarely can occur spontaneously (Birklein and Schlereth 2015; Stanton-Hicks 
et al., 1995).  
  
For the majority, CRPS resolves within a year, but prospective studies have indicated severe pain 
remains for 13% of patients ≥1 year after diagnosis (Zyluk 1998) and stiffness continues to affect up 
to 65% (Bickerstaff and Kanis 1994). Evidence synthesis of longer term retrospective studies report 
the persistence of symptoms for between 22% and 64% of patients ≥3 years after diagnosis (Bean et 
al., 2014a). Unremitting symptoms in CRPS are associated with long-term disability, poor 
psychological health and reduced quality of life (QoL) (Field et al., 1992; Geertzen et al., 1998; 
Kemler and de Vet 2000; Lohnberg and Altmaier 2013). 
 
The trajectory of long-term CRPS is not straightforward and signs and symptoms fluctuate over time. 
While many of the initial florid presenting features of CRPS may dissipate, patients may remain far 
from their premorbid health state (Birklein and Schlereth 2015; Frettlöh et al., 2006; Hush et al., 2009; 
Lewis et al., 2007). In this scenario, defining recovery from CRPS, evaluating the efficacy of 
therapeutic interventions, and setting inclusion criteria for clinical studies becomes problematic. 
 
Patients’ experience of chronic pain is moderated by multiple psychosocial, behavioural and 
physiological factors (Dansie and Turk 2013; Hush et al., 2009), and “recovery” is an individual 
construct, dependent on idiosyncratic appraisal of the impact of symptoms on daily activities (Hush et 
al., 2009).  People adjust to accommodate their changed health status, leading to “response-shift”: a 
recalibration, re-evaluation or reprioritisation of health standards (Sprangers and Schwartz 1999). 
This can confound traditional pre- and post-intervention assessments (Osborne et al., 2006). 
Furthermore, where there may be limited physical signs of an obvious cause of persistent pain and 
disability, such as long-term CRPS, “recovery” is a far from simple construct (Beaton et al., 2001).  
 
Recommendations from the Initiative on Methods, Measurement, and Pain Assessment in Clinical 
Trials (IMMPACT) promote patient-centred research, and advocate allowing patients to describe what 
is important to them when defining recovery (Dworkin et al., 2008).  
 
To achieve a comprehensive understanding of patient-defined recovery, and the factors that influence 
this, an international consortium was established in 2012 comprising patients, clinicians and 
academics from eight countries across Europe and North America. Consortium members either had 
research or clinical expertise in CRPS, relevant methodological expertise, or could represent the 
patients’ perspective for this condition. We present here findings from a 2-Round Delphi-based study 
aiming to define recovery from CRPS from the patients’ perspective.  
 
 
2. METHODS 
2.1. Ethical approvals and funding 
UK National Health Service (NHS) Ethical and Research and Development approvals were obtained 
for the study as a whole, and within this, individual centres obtained local institutional and health 
services approvals. All approvals were seen by the lead centre (UK) prior to data collection 
commencing. In addition, participants recruited from pre-existing site specific, or country specific, 
registries and databases had given prior consent to be contacted for future research purposes.  
Participants’ consent was otherwise assumed by the return of completed questionnaires.  
 
2.2. Development of study protocol  
Five workshops were convened between July 2012 and January 2015 (see Figure S1). All workshops 
were conducted following a structured format with clear aims, objectives and specified methodological 
formats. All decisions were subject to majority consensus between workshop attendees. Further 
details of each workshop are given below.  
 
2.2.1. Workshops 
Workshop 1: 
Within this workshop the theoretical, ethical and methodological frameworks for the study and content 
of the Round 1 study questionnaires (quantitative and qualitative) were agreed. Standardised patient-
reported outcome measures were identified, and questions developed to investigate participants’ 
definitions of recovery.  
 
Workshop 2: 
A structured 2-day skills workshop was held for a core team of Expert Patient Researchers and 
academic researchers, to ensure competence and consistency in the qualitative data analysis 
approach. The Consortium agreed to use the World Health Organisation’s (WHO) International 
Classification of Functioning, Disability and Health (ICF) (World Health Organization, 2001) framework 
to guide coding categorisation (Figure S2). This framework had previously been used successfully by 
RP and FB (Boogaard et al., 2011; Brunner et al., 2008; Brunner et al., 2010).   
 
Workshop 3: 
Within this workshop, recruitment activity and data collection to date were discussed and consensus 
reached how the coding framework would be applied for the on-going qualitative data analysis.  
Consortium members assessed and confirmed the standardisation of the initial coding using early 
Round 1 qualitative data. 
 Workshop 4: 
This was held to review the emergent themes from the qualitative analysis of the Round 1 data and to 
agree the wording and analysis strategy for Round 2 data. Consortium members reached consensus 
about which statements comprehensively represented patients’ perceptions of recovery and the 
content of the Round 2 questionnaires. 
 
Workshop 5:  
Full qualitative results from Round 1 were presented, and findings from preliminary analyses of the 
quantitative data were reviewed. A strategy was agreed for further data analysis and dissemination of 
all study findings. 
 
2.3. Study participants 
Potential participants ≥18yrs who had met the Budapest CRPS diagnostic criteria (Type 1 or Type 2, 
confirmed by clinical records) (Harden et al., 2010) were identified from 8 country-specific CRPS 
databases or clinic-specific research lists: UK (Bath), Germany (Mainz; Erlangen, Fürth), USA 
(Chicago), Canada (Toronto; Longueuil, Quebec), Switzerland (Zurich), Denmark (Aarhus), the 
Netherlands (Trauma RElated Neuronal Dysfunction (TREND) Consortium) and Poland (Pomerania). 
Participants were included if they were able to understand the written documents, as subsequently 
indicated by return of a completed questionnaire. (Documents were provided from each study centre 
in the language concordant with what was spoken in that country. See section 2.4.3.) Exclusion 
criteria were a diagnosis of CRPS following any cerebrovascular problems or cardiac event.  
 
To achieve a more or less equal distribution of relevant patient characteristics across countries, and 
taking into account that we wanted to be able to form strata based on gender, age (3 groups), disease 
duration (3 groups) and employment status (yes/no), we aimed to recruit 36 patients per country. With 
9 countries (we counted Canada as 2, because the two institutes are in different language areas), this 
totalled 324 patients. Considering a non-response rate of 50%, we calculated we would have to send 
out at least twice this number of questionnaires. We ultimately sent out questionnaires to 679 
potential participants. 
 
Each centre was responsible for local recruitment, with purposive sampling used to capture a range of 
disease durations and employment statuses (Mays and Pope 2000). Potential participants were sent 
a letter of invitation by post, except for newly diagnosed patients (≤1 year CRPS duration) not yet 
recruited to a CRPS database. In these cases, eligibility was determined by a member of each site’s 
clinical team, and a letter of invitation was provided to participants when attending that site’s 
outpatient clinic. Individual centres were responsible for all data collection from participants they 
recruited. 
 
Only those participants who completed Round 1 documentation were potential study participants for 
Round 2 of the study.   
 
2.4. Procedure  
2.4.1. Round 1 
The invitation mailing included: a Round 1 questionnaire pack (Part A and a sealed envelope 
containing Part B); an envelope for the completed Part A questionnaires; and a pre-paid envelope for 
the return of all completed documents. Part A questions asked for demographic information (date of 
birth, gender, employment status, years of formal education, limb affected, hand dominance); 
participants’ perception of what stage they were in the disease (early, late, recovering, recovered); 
whether they had CRPS type 1 or 2 (with no, or known, major nerve damage respectively); the date 
the patient believed the CRPS symptoms started; and whether they cared for other family members 
inside/outside of the home. Participants were asked to indicate if they considered themselves a) not 
recovered from CRPS, b) partially recovered from CRPS or c) fully recovered from CRPS. Instructions 
against responses to a) or b) asked participants to answer the open question in fewer than 100 words: 
“I would consider myself recovered from CRPS if ….”.  Where participants indicated c) (they had 
recovered from CRPS), instructions asked them to answer: “I do consider myself recovered from 
CRPS because ….” 
 
Part B questions asked: the date the participant’s CRPS commenced; whether the CRPS symptoms 
were related to trauma or were spontaneous; and what other health conditions affected the 
participant’s life. To give an indication of disease status, participants were asked to indicate which 
symptoms (from a list of fifteen derived from the Budapest CRPS criteria) they had experienced in the 
prior 48 hours. They were also asked to complete a number of standardised health outcome 
questionnaires, further details of which are given below in section 2.4.3. 
 
Written instructions made it clear to participants that they should complete the Part A questionnaires 
and seal their responses in the envelope provided before opening the envelope containing Part B and 
completing the questionnaires contained inside. This was to ensure that responses to the open-ended 
question were not prejudiced by completion of the standardised health questionnaires.  However, as 
questionnaires were completed in patients’ homes, we had to rely on their voluntary adherence to this 
protocol. Participants were asked to return all questionnaires to their local study centre in a provided 
prepaid envelope within two weeks of the date of their letter of invitation. 
 
Study questionnaires had been pre-tested with a small number of patients in the UK and the USA for 
usability and modified as required prior to ethical approvals being obtained.  All questionnaire packs, 
irrespective of language or study centre, were printed and compiled in the lead (UK) centre for 
consistency, prior to posting to each recruitment site.  
 
2.4.2. Round 2 
Derived from responses to the open question in Round 1 (as described above), participants who had 
submitted completed questionnaires were presented with 62 statements relating to perceptions of 
recovery (see Results).  These statements had been listed in random order and translated as 
necessary. Added to this was a further statement (number 63): “I do not find any of these statements 
important with regards to my recovery from CRPS”. Participants were asked to complete the 
statement: “My idea of recovery from CRPS is….” by selecting, from the statements, the 10 they felt 
were most relevant to their idea of recovery from CRPS. A minimum of 3 statements was specified for 
those who felt unable to select 10. Participants were then asked to rank their selected statements in 
order of relevance (where 1 = most relevant, 2 = second most relevant and so forth). The 
standardised health outcome questionnaires (see section 2.4.3) used in Round 1 were also repeated 
in Round 2. 
 
2.4.3. Standardised health outcome questionnaires: 
The Radboud Skills Questionnaire (RASQ) (Oerlemans et al., 2000) (for those with upper limb CRPS 
only) is a self-report questionnaire of upper limb physical function in CRPS. It contains items 
representing the 'disabilities due to hand disease' domain, of the Dutch elaboration of the International 
Code of Impairments, Disabilities and Handicaps. The RASQ questionnaire comprises 45 items 
across 11 categories, including personal care, domestic and other activities.  
 
The Measuring Activity Limitations in Walking Questionnaire (v.5) (Roorda et al., 2004) (for those with 
lower limb CRPS only) is a self-administered questionnaire, appropriate for all age groups living at 
home with lower-extremity disorders. Items ask patients about what they can actually do, rather than 
what they think they can do, in terms of walking. Not all of the 41 items are required (Roorda et al., 
2005) and 35 items relating to walking at home and walking outside were selected for use in the 
present study, with permission from the developer. 
 
The Short Form McGill Pain Questionnaire (Melzack 1987) is a self-report questionnaire providing a 
comprehensive assessment of subjects’ pain. It includes a 0-10 visual analogue rating scale of pain 
intensity and a list of 15 pain descriptors to capture pain quality.  
 
The Short Form Health Survey (SF-36) Questionnaire (Ware et al., 1993) is a self-report measure of 
subjective health status comprising 36 items across eight dimensions: physical function, social 
function, role limitations due to emotional problems, role limitations due to physical problems, mental 
health, energy/vitality, pain and general health perception.  
	
The EQ-5D-3L (The EuroQoL Group 1990) descriptive system contains five dimensions: mobility, self-
care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no 
problems, some problems, and extreme problems. It It is applicable to a wide range of health 
conditions and treatments, and can provide an index value for health status.  
 
The Acceptance and Action Questionnaire II (AAQ-II) (Bond et al., 2011) is a self-report measure of 
10 items and was used in the present study to assess patients' ability to accept unwanted emotional 
experiences or thoughts arising from their experience of pain. It is suitable for use with chronic pain 
patients, and prior findings suggest greater acceptance leads these patients to function better and to 
suffer less (McCracken and ZhaoO'Brien 2010).  
 
Where translations of study documentation from English were required (e.g. the patient information 
sheet, some outcome measures) these were provided by individual study centres for their respective 
country: Danish (Demark); French (Canada – Quebec); German (Germany – Mainz and Erlangen, 
Switzerland; Polish (Poland) and Dutch (the Netherlands). This process was followed in reverse to 
translate qualitative study data into English. The translation process followed an iterative forward and 
backward approach with two translators, who were both fluent in the relevant two languages (one was 
the local study investigator and the other was independent from the study) to ensure consistency of 
meaning across countries. This followed a tried and tested validated process as previously used 
successfully by study collaborators (FB, RP, JM) (Heitz et al., 2010). Validation of new language 
versions of the outcome measures was conducted concurrently with this study. 
 
2.5. Data Analysis 
Quantitative and qualitative data were anonymised in each participating site, translated into English 
where required (as described above), and entered into a bespoke Microsoft Excel study template. 
These anonymised data were then sent electronically to the lead (UK) centre. Whilst we had asked 
participants to state whether they were non-recovered, partially recovered or fully recovered (as study 
consortium members felt only offering dichotomous recovered/non-recovered response options might 
be uncomfortable for some patients), for the purposes of study data analyses, partially-recovered and 
non-recovered data were combined under the category “non-recovered”. Similarly, as the treatment 
for CRPS 1 and 2 is the same according to IASP criteria and the challenges around definitions of 
recovery are the same, we did not differentiate between type 1 and type 2 in our analysis.   
 
2.5.1. Quantitative Data 
Data were analysed to identify frequency of recovery/non-recovery, gender, age, duration and 
location of CRPS and whether CRPS onset was spontaneous or followed trauma (e.g. fracture). The 
frequency of individual symptom reporting by recovery/non-recovery was also identified. Chi-squared 
tests of association were used to detect associations between the number of reported symptoms and 
self-reported recovery, and between recovery and demographic characteristics. Data from the non-
recovered sub-sample were further examined with Odds Ratio analyses and Welch’s t-tests to 
determine associations between symptoms and the limb that was affected (upper or lower - data from 
patients with CRPS in both upper and lower limbs were excluded from these analyses). The study 
was explorative in nature, hence no hypotheses of differences, or comparisons of data, between each 
country were made. 
 
To analyse the Round 2 data, statements selected and ranked by participants were weighted for 
importance (priority 1=100%, 10=10%) and cumulative weighted percentages calculated for those 
statements quoted by ≥5% of respondents, in order to identify the top 5 statements overall. Sub-group 
analyses identified the top three statements by geographical region, gender, recovery status 
(recovered/non-recovered), age, employment, duration and site of CRPS. 
 
2.5.2. Qualitative Data 
Training in thematic analysis was provided by FB and RP for a core analysis team of Expert Patient 
and academic researchers (IT, CS, YH, FB & RP). On receipt of completed questionnaires, Round1 
data were entered on to a common electronic template and transferred electronically to a single site 
(at the RNHRD, Bath UK). YH conducted an initial analysis of early responses using deductive 
analysis with QSR NVivo in order to identify the emerging themes (Braun and Clarke 2006). These 
themes were then categorised according to the World Health Organisation’s (WHO) International 
Classification of Functioning, Disability and Health (ICF) (World Health Organization 2001) framework. 
The core analysis team and other members of the Consortium (selected based on their previous 
experience/knowledge of content analysis and to ensure representation across the participating 
countries), also jointly analysed a sample of data to ensure consistency of coding and subsequent 
categorisation according to this framework.  
 
YH subsequently completed the data coding, analysing the data from non-recovered participants 
separately from that received from recovered participants, and consulting with the core analysis team 
for guidance where required. The core analysis team members reached consensus about any 
phrases not immediately fitting the classification system and where several different terms were 
judged by the researchers to describe the same issue, these were grouped together to form a 
universal description (Hasson et al., 2000). Editing of the original phrases and words was otherwise 
kept to an absolute minimum. Descriptions and grouping systems were also verified by two other 
members of the research team and by two other Expert Patient Researchers to confirm inter-rater 
reliability.  
 
The frequency of themes within the data was noted for both the recovered and non-recovered 
subgroups and the top 50% of themes extracted.   Led by JM, the Consortium members considered 
the statements for each of these themes that were felt to best represent patients’ perceptions of 
recovery. The final agreed items were listed in a random order to form the questionnaire for Round 2.  
 
 
3. RESULTS 
3.1 Qualitative data 
Round 1 questionnaires were sent to 679 patients and were returned by 347 (51%, 80% female, 91% 
non-recovered, 53% disease duration ≥ 3yrs, mean age 53 years (range 18-85)) (See Table 1).  
 
[Insert Table 1 here] 
 
Dominant themes from the open text responses to the qualitative question about patient-defined 
recovery were as presented in Table 2. When these themes were categorised under the main WHO 
ICF framework, the majority of data fell into four key headings: activities of daily living; bodily functions 
and structures (including symptoms and pain); external factors (including medication use) and 
participation (e.g. housework, shopping). Personal factors (anxiety, depression) were least 
represented. Please see Table S1 for illustrative quotes from the most frequent themes, showing how 
these were categorised within the ICF framework, and indicating the country of origin of each quoted 
participant. 
 
[Insert Table 2 here] 
 
From the analysis of the Round 1 data, 62 statements were identified to represent the dominant 
themes of patient-defined recovery (See Table 3). These formed the basis of the Round 2 
questionnaire, which was sent to the same 347 patients who had responded in Round 1.   
 
[Insert Table 3 here] 
 
3.2 Quantitative data 
Of the 347 Round 1 participants, 310 reported their recovery status and completed symptom and 
standardised health outcome questionnaires:  280 (90.3%) “non-recovered”; 80% female; average 
age 52 years (range 19-85 years); 51% disease duration ≥3 years. Responses to other demographic 
questions showed: 70/40% upper/lower limb affected (some having CRPS in both an upper and lower 
limb); 55/53% right/left side affected (some having bilateral CRPS); 91/9% trauma-precipitated / 
spontaneous onset of CRPS. Responses to the standardised health outcome questionnaires are 
presented in Figure S3. 
 
Both “non-recovered” and “recovered” participants reported symptoms in the prior 48 hours (see 
Table 4).   The three most frequently reported symptoms for “non-recovered participants” were: 
muscle weakness (90%); a decreased range of motion in the affected limb (87%); and temperature 
differences from side to side (78%). This was also true for participants who classified themselves as 
“recovered”: 31% reported muscle weakness; 33% a decreased range of motion; and 27% 
temperature differences.  
 
[Insert Table 4 here] 
 
Self-reported recovery and number of symptoms were strongly associated (χ2 = 124.94, df = 15, p < 
.001). For those reporting <5 symptoms, 34% reported themselves as recovered, compared to 2% of 
those with 5 or more symptoms. There were no associations between self-reported recovery status 
and gender, disease duration, whether onset was post trauma or spontaneous, or limb affected.   
 
Non-recovered participants with lower-limb CRPS more frequently reported allodynia (OR 1.93, CI = 
1.12 – 3.33, p = .021), hyperalgesia (OR 2.60, CI = 1.40 – 4.83, p = .003), changes in hair growth (OR 
1.86, CI = 1.08 – 3.21, p = .035), and involuntary muscle movements (OR 1.78, CI = 1.05 – 3.04, p = 
.042) than those with upper-limb CRPS. They also had poorer MPQ (p < .01), EQ-5D (p < .05), SF-36 
Physical Functioning (p < .001) and Energy/Fatigue (p < .05) scores (see Table 5). 
 
[Insert Table 5 here] 
 
Round 2 responses, whereby patients ranked the relevance of the 62 statements, were received from 
252 patients (73%, 77% female, 90% non-recovered) (see Table 6). The statements ranked as the 
top five priorities across the whole sample were: no longer having 1) CRPS-related pain, 2) 
generalised pain and discomfort, 3) restricted range of movement, 4) need for medication, and 5) 
stiffness in the affected limb/s. These themes were mirrored in the top three statements for each 
geographical region, apart from: having improved sleep and rest (UK, Denmark), and no longer 
having involuntary movement in the affected limb/s (The Netherlands). 
 
The top three statements of most subgroups (males, females, recovered, non-recovered, age groups 
30-50 and 50+, paid employment, non-employed, all disease durations, upper and lower limb CRPS) 
were all within the overall top five priority list. Individual exceptions were: having a better QoL 
(participants aged 18-30) and improved sleep and rest (non-paid workers). 
 
[Insert Table 6 Here] 
 
4. DISCUSSION 
While it is known that CRPS can resolve spontaneously, studies suggest that for some patients, 
symptoms can persist and lead to long term-disability (Bean et al. 2016; Beerthuizen et al. 2012; De 
Mos et al. 2009).  The primary aim of this international study was to define recovery from the patients’ 
perspective, and to understand the factors that may influence this.  
 
When each participant was asked to describe what would lead them to consider themselves 
recovered from CRPS, responses showed, that patient-reported impacts of CRPS fall across the 
breadth of the WHO ICF categories. The largest number of reports related to: activities of daily living; 
bodily functions and structures (including symptoms and pain); external factors (including medication 
use), and participation (e.g. housework, shopping).  These findings support prior studies suggesting 
CRPS interferes with many aspects of life including self-care, work and mobility (Kemler and de Vet 
2000; Sharma et al., 2009). 
 
Interestingly, psychological factors, such as anxiety and depression, which fall within the ICF 
“personal factors” category, were least represented amongst the themes patients reported as 
important for recovery. The literature on the role of psychological factors in CRPS is contradictory. 
While some studies suggest psychological factors have little bearing on the development and 
longevity of CRPS (Beerthuizen et al. 2009; Beerthuizen et al. 2011; Puchalski and Zyluk 2005), 
others have found associations between CRPS outcomes and anxiety (Bean et al. 2015; Bean et al. 
2014b; Dilek et al. 2012). In our study, patient research partners within the research team, suggested 
affect is a consequence of CRPS symptoms, not a symptom per se. Previous research has similarly 
concluded altered psychological functioning is a natural outcome of chronic pain, rather than a 
specific psychological profile characteristic of CRPS patients, (Lohnberg and Altmaier 2013). 
Furthermore, the phrasing of our open question may have elicited patients’ primary complaints, such 
as pain and function, rather than secondary consequences of these symptoms, such as psychological 
distress. 
 
Through selection and ranking of the most important factors that would enable participants to 
personally consider themselves recovered, participants reported they want, in priority order: to be 
relieved of CRPS pain, and generalised pain and discomfort; to have improved movement; and to 
have a reduction in medication, and stiffness in their limbs.   
 
Given the intensity of CRPS pain, we were not surprised that this was patients’ highest priority. 
However, the frequency with which the factor: “generalised pain and discomfort” was identified by all 
sub-groups, was unanticipated. Widespread muscle hyperalgesia affecting non-CRPS affected limbs 
and the cheek area, has previously been reported in CRPS patients with longstanding disease (van 
Rooijen et al., 2013). It is considered most likely this unspecific pain relates to central sensitization, a 
process in which innocuous stimuli become, and remain painful in chronic pain conditions, such as 
CRPS (Goebel 2011). Our findings underline the importance of using measures to capture non-
specific, as well as distinct, CRPS pain in research and clinical practice, and to consider both aspects 
when determining therapeutic interventions. 
 
A recent qualitative study, exploring what patients consider important to recovery following hip 
fracture, found mobility, and its relevance to personal care and valued day-to-day activities, was the 
most important factor (Griffiths et al., 2015). Our data similarly suggest that while reduction of pain 
remains a fundamental treatment aim, the patients’ desire for restoration of function supports 
multidisciplinary treatment approaches focussing on the goals and needs of daily living. 
 
We are not aware of previous studies that have specifically identified the importance of reducing 
reliance on medication, when defining recovery in musculoskeletal conditions. Whilst medication may 
be one cornerstone for the treatment of chronic pain, our data suggests that people with CRPS may 
value exploring non-pharmacological coping and treatment strategies in order to meet their goal of 
reducing medication. Cognitive behavioural approaches, such as Acceptance and Commitment 
Therapy (Hayes et al., 2006), may be helpful in this regard. 
 
There is a paucity of research into individual differences in the impacts of CRPS. However, our data 
suggest that treatment targets vary little between patients; indicating group based therapeutic 
interventions maybe as effective as more individually tailored treatment approaches. We were 
particularly interested in the consistency of factors identified by participants as most important in 
defining recovery across the subgroups. Results showed that these factors were mostly irrespective 
of gender, recovery status, age, employment status, disease duration and site of CRPS (upper or 
lower limb).  The minor country-specific differences we saw could be attributable to referral variation. 
For example, CRPS clinicians in The Netherlands have particular expertise in CRPS-related 
movement disorders and this may explain why resolution of involuntary movements was a particular 
priority for the Netherlands cohort.  
 
Muscle weakness and decreased range of motion were the most frequent symptoms reported by 
participants in our quantitative data.  These findings correspond to the importance of improved motor 
function and reduced stiffness, as identified as recovery priorities in our qualitative data, and underline 
the importance of addressing factors affecting physical function in CRPS treatment pathways. While 
temperature differences between the affected and unaffected limb were also frequently reported 
symptoms, our findings suggest autonomic features are considered by patients to be less important in 
their definition of recovery than aspects of their condition that deleteriously impact daily activities. 
 
Interestingly pain was not among the most frequently reported symptoms, despite it being identified 
as of highest importance to recovery. It is possible that these, seemingly contradictory findings may 
be the product of response shift (Schwartz et al. 2007), and the nature of the dichotomous questions 
asked. In our study, patients were asked whether or not, in the last 48 hours, they had experienced 
“pain going on longer than expected/greater than expected” and whether stimuli that “normally do not 
cause pain”, or “normally cause only slight pain” had been painful/more painful. It is plausible that 
participants’ acceptance of their everyday pain meant they only reported pain beyond that which was 
typical for them, and which they already considered as “normal”.  
 
Given the nature of CRPS, and the breadth of symptoms in diagnostic criteria, it is unsurprising our 
data showed, that the likelihood of a participant considering him/herself to be recovered was closely 
related to the number of symptoms reported. However, even those who classified themselves as 
“recovered”, had still experienced symptoms in the prior 48 hours. In a similar way, post myocardial 
infarction, patients have also reported recovery as an ongoing and unstable process of learning to live 
with feeling “different” from before (Tod 2008). This presents an interesting insight into how people 
conceptualise recovery and suggests that it is more complex than the simple absence or presence of 
symptoms. Within this context, it poses the question what constitutes appropriate treatment to 
address the residual functional needs people with CRPS. For example, should people who no longer 
meet the diagnostic criteria, but who nevertheless have ongoing disabling symptoms, still be offered 
the full breadth of “usual” CRPS care, or should they receive more specific approaches, individually 
tailored to their remaining functional impairments? Future studies are needed to determine the most 
functionally beneficial and cost effective solutions across the disease trajectory. 
 
Sub-group analysis of our quantitative data from non-recovered patients, indicated poorer outcomes 
for those with lower limb CRPS, than those with CRPS of the upper limb. This was true for our 
standardized measures of pain, physical functioning, QoL and energy/fatigue. These findings fit well 
with previous work citing lower self-reported QoL in the physical domain of the SF-36, for those with 
lower limb CRPS (van Velzen et al., 2014). 
 
A contributing factor to these poorer outcomes in lower limb CRPS may be our finding that these 
participants had a higher mean pain score on the MPQ, and more frequently reported allodynia and 
hyperalgesia, than those with upper limb CRPS.  Furthermore, they more frequently reported changes 
in hair growth and involuntary muscle movement.  Involuntary movements have been previously 
reported to occur significantly more often in CRPS affected legs than arms (Frettlöh et al., 2006). 
Beyond the respective prevalence of upper and lower limb CRPS, we are not aware of any other 
studies that have compared and contrasted the incidence and specificity of symptoms according to 
localization. More research is needed to understand the differential implications of CRPS site, on 
patient outcomes. 
 
A limitation of our study was the small "recovered" sample (9%). This sample was probably a 
consequence of our pragmatic recruitment strategy, approaching participants from CRPS databases 
and research lists. The greater duration of CRPS, the more likely a patient would be enrolled into a 
condition-specific database. Furthermore, those who are fully recovered may be less inclined to 
complete a CRPS-focused questionnaire, as it lacks relevance to them any more.  A lack of statistical 
power in the available sample size therefore precluded analysis of between group differences. 
 
We are mindful that our study was reliant on self-report of symptoms, which were not clinically verified 
and that this may be considered a study limitation. Furthermore, much of the outcome measure data 
was unique to the study protocol and therefore only available for those who completed and returned 
the questionnaires. For this reason, and because clinical records differ greatly between countries, we 
were unable to investigate any potentially significant differences between those who did, and did not 
return questionnaires. Future studies with greater equipoise between recovered/non-recovered 
cohorts, the inclusion of a clinical assessment, and consideration of study participant/non-participant 
data would be informative. 
 
Our data adds a unique perspective to current understanding of recovery, as defined by patients. Our 
findings suggest a very small number of themes are of highest importance to people with CRPS in 
their definition of recovery, and these vary little with demographics. Irrespective of where a person 
with CRPS is in the disease trajectory, and whether or not they still meet diagnostic criteria, they want 
their CRPS-related pain, generalised pain, movement difficulties, and medication reliance to be 
addressed, above all other factors, for them to consider themselves recovered. These factors should 
therefore be considered as foremost in the development and design of future treatments and 
multidisciplinary rehabilitation programmes. 
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Patient Characteristics N % 
Gender   
Male   68 19.7  
Female 277 80.3 
Mean age (SD) (Range)   53 (12.91) (18-85)  
Employment status   
Employed/self employed   92 27.0 
Employed part time   41 12.0 
Housewife/husband   27   7.9 
Unemployed   21   6.2 
Voluntary worker     2   0.6 
Retired   79 23.2 
Ill-health retired   59 17.3 
Student     8   2.4 
Other   12   3.5 
Mean years in education from age 6 (SD) (Range)   18 (21.35) (3-25)  
Site of CRPS†   
Upper right limb 138 39.8 
Upper left limb 119 34.3 
Lower right limb   80 23.1 
Lower left limb   85 24.5 
Dominant hand   
Right 303 88.3 
Left   40 11.7 
Disease duration   
Less than 1 yr   42 12.3 
1-3 years 120 35.1 
≥ 3 years 180 52.6 
Self-reported recovery   
Recovered   33  9.5 
Non-recovered 314 90.5 
† Some participants had CRPS in more than one limb, hence summating these figures will give a total which exceeds the  
 overall sample size (N=347 / 100%). 
 
Table 1. Demographic characteristics of Round 1 sample.
 
Canada Denmark Germany Netherlands Poland UK USA Switzerland 
Pain Sensations Pain Sensations Pain Sensations Pain Sensations Muscle and 
Movement 
Functions 
Pain Sensations Pain Sensations CRPS 
Symptoms 
Medical Services CRPS 
Symptoms 
Muscle and 
Movement 
Functions 
Mobility Pain Sensations CRPS 
Symptoms 
Recreation and 
Leisure 
Pain Sensations 
CRPS 
Symptoms 
Mobility CRPS 
Symptoms 
CRPS 
Symptoms 
CRPS 
Symptoms 
Mobility CRPS 
Symptoms 
Mobility 
Domestic Life Sleep Functions Mobility Domestic Life Mobility Recreation and 
Leisure 
Muscle and 
Movement 
Functions 
Recreation and 
Leisure 
Recreation and 
Leisure 
Work and 
Employment 
Psychological 
Factors 
Muscle and 
Movement 
Functions 
Medical Services Muscle and 
Movement 
Functions 
Self Care Muscle and 
Movement 
Functions 
Mobility Muscle and 
Movement 
Functions 
Sleep Functions Recreation and 
Leisure 
Self Care Self Care Functioning as 
Normal 
Sleep Functions 
Muscle and 
Movement 
Functions 
Recreation and 
Leisure 
Medical Services  Carrying Out 
Daily Routine 
Domestic Life Reproductive 
Functions 
Self Care 
Sleep Functions Restlessness Usage of 
Computer & 
Writing 
 Domestic Life Carrying Out 
Daily Routine 
Medical Services Medical Services 
Self Care Medical Services Functioning as 
Normal 
 Sleep Functions Medical Services Work and 
Employment 
Work and 
Employment 
Psychological 
Factors 
Self Care   Work and 
Employment 
Work and 
Employment 
CRPS Ruling 
Life 
Domestic Life 
 Life Before 
CRPS 
   Psychological 
Factors 
Psychological 
Factors 
Psychological 
Factors 
 
Table 2. Top 50% of themes in rank order from Round 1 data by participating country
 
1. If I did not have involuntary movement (incl. tremor) and cramps in my affected limb/s 
2. If I could go shopping 
3. If I did not suffer from temperature changes in my affected limb/s 
4. If I did not have increased muscle tension in my affected limb/s 
5. If I was not restless 
6. If I did not have colour changes in my affected limb/s 
7. If I could use stairs 
8. If the appearance of my limb/s was/were normal 
9. If I could generally have more confidence 
10. If I was not depressed 
11. If I was less tired 
12. If I could feel good inside 
13. If I could take part in indoor activities – hobbies 
14. If I did not need medication 
15. If I was able to prepare my hair and nails 
16. If I did not have feelings of negativity 
17. If I did not have fear / worries 
18. If I had a better quality of life 
19. If I could drive a vehicle 
20. If I did not need the use of medical aids (e.g. crutches) 
21. If I could wash clothes 
22. If I did not have skin changes in my affected limb/s 
23. If I could wear the clothing and jewellery of my choice  
24. If I could feel acceptance of CRPS 
25. If I did not have CRPS related pain in my limb/s anymore 
26. If I did not have hair and nail changes in my affected limb/s 
27. If I could live independently 
28. If I could return to work and employment 
29. If I did not have stiffness in my affected limb/s 
30. If I could stop feeling useless 
31. If I could eat (normally) 
32. If I could travel more 
33. If I could walk 
34. If I did not have generalised pain and discomfort 
35. If I could carry out my daily routine 
36. If I could feel in control 
37. If I could stand 
38. If I was not affected by sweating in my affected limbs  
39. If I could do housework 
40. If I could wash and toilet independently 
41. If I had more stamina 
42. If I could prepare meals 
43. If I did not have internal agitation 
44. If I could take part in family activities 
45. If I could carry, handle and move objects 
46. If I did not have headaches  
47. If I did not have limb swelling 
48.   If my sleep & rest improved 
49. If I did not have muscle weakness in my affected limbs 
50. If I did not feel stress 
51. If my limb felt it belonged to me  
52. If I could write better 
53. If I could receive the right medical treatment  
54. If I could feel at ease 
55. If I could dress myself 
56. If I could take part in more sports and exercise 
57. If I could have a clear mind 
58. If I could use a computer 
59. If I did not have mood swings  
60. If I could take part in a social life 
61. If I did not have restricted range of movement in my affected limb/s 
62. If I could take part in outdoor activities/hobbies 
63. I do not find any of these statements important with regards to my recovery from CRPS. 
 
Table 3. Statements representing patients’ definitions of recover, derived from Round 1 data. 
 
 Responses to Recovered / 
Non-Recovered question 
(N=310) 
 Non-recovered Recovered 
% Yes response to: n=280 n=30 
Pain going on longer than expected, pain greater than 
expected. 
63.4 17.9 
Stimuli that normally do not cause pain are painful now. 57.8 13.8 
Stimuli that normally only causes slight pain are now 
painful 
67.9 17.2 
Temperature differences from side to side 78.1 26.9 
Colour differences from side to side 63.1 16.7 
Sweating differences from side to side 51.3 10.3 
Swelling (oedema) of affected limb 70.7 23.3 
Changes to the growth of your nails on affected part 45.3 16.7 
Changes to the growth of hair on affected part 37.5 13.3 
Changes to the appearance of your skin on affected part 69.1 20.0 
Muscle weakness in affected limb 89.9 31.0 
Involuntary muscle tremors, or shaking 55.1 6.7 
Sustained muscle contractions resulting in involuntary 
positioning of limb 
46.5 10.0 
Decreased range of motion in affected limb 87.0 33.3 
Involuntary muscle movements. 47.8 13.3 
 
Table 4. Percentage reporting specific symptoms by self-reported recovery status   
  Non-Recovered participants with CRPS in:    
  Lower limb only  Upper limb only     
Measure  n Mean SD  n Mean SD  t p D 
             
AAQ  76 46.99 13.69  159 48.29 11.87  0.71 .478 0.105 
MPQ  81 25.08 11.37  140 20.86 11.48  2.65 .009 0.371 
EQ5D  78   0.39   0.36  162   0.51   0.34  2.42 .017 0.341 
SF-36             
Physical 
Functioning 
 84 40.11 27.48  165 62.81 22.70  6.52 <.001 0.934 
Physical 
Health 
 84 18.15 31.61  165 25.30 37.35  1.59 .115 0.202 
Emotional 
Problems 
 83 38.55 42.76  165 44.65 45.16  1.04 .300 0.134 
Energy/Fatigue  84 36.17 22.92  166 43.96 21.22  2.60 .010 0.358 
Emotional 
Well-being 
 84 53.22 22.20  166 57.41 22.24  1.41 .161 0.189 
Social 
Functioning 
 84 49.85 26.57  166 56.85 29.31  1.90 .059 0.247 
Pain  84 34.38 23.30  166 38.42 26.65  1.23 .219 0.159 
General Health  83 46.93 23.70  166 47.35 23.05  0.13 .894 0.018 
 
Table 5. Mean measures by lower limb only and upper limb only (t denotes absolute t-value in 
Welch’s t-test; p the corresponding p-value, and d denotes the sample estimate of Cohen’s 
d).
 
 Overall top five statements, N=252 
 Statement number Weighted % score  
 25 51.03 If I did not have CRPS related pain in my limb/s any more 
 34 28.19 If I did not have generalised pain and discomfort 
 61 22.93 If I did not have restricted range of movement in my affected limb/s 
 14 20.39 If I did not need medication 
 29 15.46 If I did not have stiffness in my affected limb/s 
 Sub groups Geographical area† Gender Recovery 
Status 
Age Duration of 
CRPS 
Employment 
status 
Limb 
affected†† 
 
Top three recovery statements 
1 = first priority 
2 = second priority 
3 = third priority N
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ll n=     53 54 35 23 35 21 31 49 161 189 21 11 63 130 28 68 116 71 21 111 169 90 
If I did not have CRPS related pain in my limb/s 
any more 1   1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
If I did not have generalised pain and discomfort 3 3 2  2 2  3 2 2 2 2 3 3  2 3 2  2 3 3 
If I did not have restricted range of movement in 
my affected limb/s  1 3 2 3    3  3   2 2   3 3 3 2  
If I did not need medication 2 2     3 2  3   2   3 2     2 
If I did not have stiffness in my affected limb/s   1            3        
 If my sleep and rest improved      3 2            2    
 If I did not have involuntary movement (incl. 
tremor) and cramps in my affected limb/s    3                   
 If I had a better quality of life            3           
† Individual participants were not identifiable from Swiss Round 2 data and are therefore not included in other demographic sub-group totals. 
†† Some participants had CRPS in both an upper and lower limb. 
 
Table 6. Statements identified by participants as most important to their definition of recovery from CRPS
 
 
